Delivery Order SPE2DB22D2006-SPE2DB25FW4FR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $20,650.18 to AmerisourceBergen Drug Corp for HUMIRA(CF) Pen 40 mg/0.4 mls, a rheumatoid arthritis and autoimmune disease treatment. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $12,823.53 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed price, non-competitive delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. HUMIRA is a widely used...
- The Defense Logistics Agency awarded a delivery order valued at $7,959.80 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a rheumatoid arthritis and autoimmune disease treatment. This firm fixed-price, non-set-aside contract was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award represents a single task issued under a...
- The Defense Logistics Agency awarded a delivery order valued at $1,768.16 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used for treating autoimmune conditions. The contract was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $9,883.59 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered from...
- The Defense Logistics Agency awarded a delivery order valued at $2,129.13 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a prescription pharmaceutical product used to treat inflammatory conditions. This firm fixed-price delivery order, awarded on September 15, 2025, is set to conclude on September 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitive award with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,458.01 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a brand-name pharmaceutical product used to treat autoimmune conditions. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, and utilized firm fixed-price pricing under a non-set-aside competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mls, a pharmaceutical product for treating autoimmune conditions. The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, utilizes firm fixed pricing with no set-aside designation, indicating the award was made through open competition. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $5,700.00 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on September 12, 2025, with a completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. HUMIRA is a widely-used biologic medication for treating rheumatoid arthritis, psoriasis, and other autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This is a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and was awarded on June 16, 2025, without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW4FRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,886.97 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a brand-name rheumatoid arthritis and immunological disease treatment. This firm fixed-price, competitively awarded delivery order was executed on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order carries no set-aside designation, indicating it was awarded through open competition. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal medical procurements and demonstrates capability to meet stringent federal requirements for pharmaceutical supply and delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/16/25 |